Episode Details
Back to EpisodesPre-Session Views
Published 8 months, 2 weeks ago
Description
- Strategy| Market intelligence - Launch of Ras El Hekma should unlock IMF funding and inflate ORAS and ELEC valuations
- RMDA| Acquisition of high-margin chronic disease molecule reinforces strategic outlook and FY25 targets
- BONY| Discounted entry and an above average rent yield — but dividend void and cashflow thinness limit appeal
- ETEL| 12M rally = cost of equity
- GBCO| Another management call confirms our positive view on the stock; Margins hold firm amid regional challenges, GB Capital beats, incentives to boost 2H25 earnings
- EGAL| Hold EGAL to EGP200/share